Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria

被引：0
|
作者：
Watson, James A. [1 ]
Taylor, Aimee R. [2 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 380卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1875 / 1876
页数：2
相关论文
共 50 条
  • [31] Primaquine as anti-relapse therapy for Plasmodium vivax
    Baird, JK
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (06) : 687 - 687
  • [32] Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
    Watson, James
    Taylor, Walter R. J.
    Bancone, Germana
    Chu, Cindy S.
    Jittamala, Podjanee
    White, Nicholas J.
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (04):
  • [33] Short report:: Tafenoquine for the treatment of recurrent Plasmodium vivax malaria
    Kitchener, Scott
    Nasveld, Peter
    Edstein, Michael D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (03) : 494 - 496
  • [34] Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
    Sharma, Jatin
    Gautam, C.
    Singh, Harmanjit
    Singh, Jagjit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 154 (06) : 797 - 805
  • [35] Primaquine for preventing relapses in people with Plasmodium vivax malaria
    Galappaththy, G. N. L.
    Omari, A. A. A.
    Tharyan, P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [36] PHARMACOKINETICS OF PRIMAQUINE IN PATIENTS WITH PLASMODIUM-VIVAX MALARIA
    BHATIA, SC
    SARAPH, YS
    REVANKAR, SN
    DOSHI, KJ
    BHARUCHA, ED
    DESAI, ND
    VAIDYA, AB
    SUBRAHMANYAM, D
    GUPTA, KC
    SATOSKAR, RS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) : 205 - 210
  • [37] Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
    Duparc, Stephan
    Chalon, Stephan
    Miller, Scott
    Richardson, Naomi
    Toovey, Stephen
    MALARIA JOURNAL, 2020, 19 (01)
  • [38] IMPACT OF CYP2D6 ON PRIMAQUINE AND TAFENOQUINE EFFICACY IN <it>PLASMODIUM VIVAX</it> MALARIA PHASE 3 CLINICAL TRIALS
    St Jean, Pamela
    Koh, Gavin
    Mohamed, Khadeeja
    Duparc, Stephan
    Green, Justin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04) : 545 - 545
  • [39] Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand
    Wilairatana, P
    Silachamroon, U
    Krudsood, S
    Singhasivanon, P
    Treeprasertsuk, S
    Bussaratid, V
    Phumratanaprapin, W
    Srivilirit, S
    Looareesuwan, S
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (06) : 973 - 977
  • [40] Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
    Stephan Duparc
    Stephan Chalon
    Scott Miller
    Naomi Richardson
    Stephen Toovey
    Malaria Journal, 19
12345